J Prev Med Public Health.
2012 Sep;45(5):291-300.
The Socioeconomic Burden of Coronary Heart Disease in Korea
- Affiliations
-
- 1Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea.
- 2Institute of Health Services Research, Yonsei University College of Medicine, Seoul, Korea.
- 3Health Insurance Policy Research Institute, National Health Insurance Corporation, Seoul, Korea.
- 4Health Insurance Review and Assessment Services, Seoul, Korea.
- 5College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, Korea. hykang2@yonsei.ac.kr
Abstract
OBJECTIVES
We aimed to estimate the annual socioeconomic burden of coronary heart disease (CHD) in Korea in 2005, using the National Health Insurance (NHI) claims data.
METHODS
A prevalence-based, top-down, cost-of-treatment method was used to assess the direct and indirect costs of CHD (International Classification of Diseases, 10th revision codes of I20-I25), angina pectoris (I20), and myocardial infarction (MI, I21-I23) from a societal perspective.
RESULTS
Estimated national spending on CHD in 2005 was 2.52 billion dollar . The majority of the spending was attributable to medical costs (53.3%), followed by productivity loss due to morbidity and premature death (33.6%), transportation (8.1%), and informal caregiver costs (4.9%). While medical cost was the predominant cost attribute in treating angina (74.3% of the total cost), premature death was the largest cost attribute for patients with MI (66.9%). Annual per-capita cost of treating MI, excluding premature death cost, was 3183 dollar, which is about 2 times higher than the cost for angina (1556 dollar).
CONCLUSIONS
The total insurance-covered medical cost (1.13 billion dollar) of CHD accounted for approximately 6.02% of the total annual NHI expenditure. These findings suggest that the current burden of CHD on society is tremendous and that more effective prevention strategies are required in Korea.